Look for:

Our offer for

ABBOTT LABORATORIES


ISIN:
US0028241000
WKN:
002824100

2022/08/15 20:31:24
Price
110.40 EUR
Difference 1.79% (1.94)

General attributes

ISINUS0028241000
SymbolABT
ExchangeBerlin
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)190,388 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)109.90 EUR (910)
Ask (Ask size)110.62 EUR (904)
Open108.76 EUR
High110.40 EUR
Low108.74 EUR
Close (prev. day)108.46 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades17
Last size0

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: ABBOTT LABORATORIESPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/08/15 20:31:24
Price
110.40 EUR
Difference 1.79% (1.94)

General attributes

ISINUS0028241000
SymbolABT
ExchangeBerlin
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)190,388 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)109.90 EUR (910)
Ask (Ask size)110.62 EUR (904)
Open108.76 EUR
High110.40 EUR
Low108.74 EUR
Close (prev. day)108.46 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades17
Last size0

Performance and Risk

6m1Y3Y
Perf (%)-2.16%+3.94%+42.35%
Perf (abs.)-2.39+4.11+32.27
Beta0.950.870.91
Volatility26.5924.1327.57
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)107.10 EUR (0)
Ø price 30 days | Ø volume 30 days (pcs.)107.04 EUR (1)
Ø price 100 days | Ø volume 100 days (pcs.)106.75 EUR (8)
Ø price 250 days | Ø volume 250 days (pcs.)108.94 EUR (7)
YTD High | date124.90 EUR (2022/01/03)
YTD Low | date96.14 EUR (2022/06/16)
52 Weeks High | date125.65 EUR (2021/12/30)
52 Weeks Low | date96.14 EUR (2022/06/16)

All listings for ABBOTT LABORATORIES

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2022/08/1517:35109.26 EUR0.0412
Vienna Stock Exchange2022/08/1517:32109.26 EUR0.002
Tradegate2022/08/1520:25110.54 EUR0.2350
Stuttgart2022/08/1520:03110.46 EUR0.007
SIX Swiss Exchange2022/07/0417:30104.00 CHF0.001
NYSE2022/08/1521:12112.01 USD181.3228,305
Munich2022/08/1508:04108.40 EUR0.002
London Stock Exchange2022/08/1515:30111.31 USD0.006
Hanover2022/08/1508:21108.42 EUR0.001
Hamburg2022/08/1508:20108.42 EUR0.001
Frankfurt2022/08/1518:58110.08 EUR0.025
Duesseldorf2022/08/1520:00110.04 EUR0.0010
Berlin2022/08/1520:31110.40 EUR0.0017

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2546&ID_TYPE_IMAGE_LOGO=2

Contact Details

ABBOTT LABORATORIES
- -
100 Abbott Park Road - 60064-6400 Abbott Park
Telefon: 1-224-667-6100
Fax: -
E-mail: -

PDF Downloads

Company report: ABBOTT LABORATORIESPDF Download

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1900 and is headquartered in Abbott Park, IL.

Members of Management Board

Robert AlpernMember of Board of Directors
Sally BlountMember of Board of Directors
Daniel StarksMember of Board of Directors
Darren McDewMember of Board of Directors
Glenn TiltonMember of Board of Directors
John StrattonMember of Board of Directors
Michael RomanMember of Board of Directors
Michelle KumbierMember of Board of Directors
Nancy McKinstryMember of Board of Directors
Paola GonzalezMember of Board of Directors
William OsbornMember of Board of Directors
Robert B. FordChairman of Managing Board
John M. CapekMember of Executive Committee
Alejandro WellischMember of Executive Committee
Andrea F. WainerMember of Executive Committee
Andrew H. LaneMember of Executive Committee
Christopher J. CalamariMember of Executive Committee
Daniel SalvadoriMember of Executive Committee
Greg AhlbergMember of Executive Committee
Hubert L. AllenMember of Executive Committee
J. Scott HouseMember of Executive Committee
Jared L. WatkinMember of Executive Committee
John F. GinascolMember of Executive Committee
Joseph ManningMember of Executive Committee
Julie TylerMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer